•Dompé kicks off patient dosing in phase 3 PCED trial on cenegermin-bkbj•American Academy of Ophthalmology partners with OpenEvidence AI platform•Carrot expands VR diagnostics with real-time analytics dashboard•Atropine taper leads to less pediatric myopia progression•Harrow relaunches VERKAZIA for vernal keratoconjunctivitis •Dompé kicks off patient dosing in phase 3 PCED trial on cenegermin-bkbj•American Academy of Ophthalmology partners with OpenEvidence AI platform•Carrot expands VR diagnostics with real-time analytics dashboard•Atropine taper leads to less pediatric myopia progression•Harrow relaunches VERKAZIA for vernal keratoconjunctivitis
HEADLINES
FEATURED
The PF formulation debuts 9 months after securing FDA approval with a patented mucoadhesive lubricating gel technology for IOP reduction.
Earn FREE CE 24/7 with Courses by Eyes On Eyecare
Explore premium-quality, bite-sized courses featuring leading experts like Cecelia Koetting, OD, FAAO, and Cory Lappin, OD, MS, FAAO, and continuing education covering topics from ocular rosacea treatments to retinal disease.
